{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T04:34:06Z","timestamp":1770698046265,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1016\/s0952-7915(98)80225-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T06:32:55Z","timestamp":1027578775000},"page":"564-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Tumor expression of Fas ligand (CD95L) and the consequences"],"prefix":"10.1016","volume":"10","author":[{"given":"Paul R","family":"Walker","sequence":"first","affiliation":[]},{"given":"Philippe","family":"Saas","sequence":"additional","affiliation":[]},{"given":"Pierre-Yves","family":"Dietrich","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0952-7915(98)80225-2_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(98)80225-2_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.280.5361.243","article-title":"Homeostasis and self-tolerance in the immune system: turning lymphocytes off","volume":"280","author":"Van Parijs","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80225-2_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0952-7915(97)80082-9","article-title":"Pathways leading to cell death in T cells","volume":"9","author":"Wong","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","article-title":"Fas ligand-induced apoptosis as a mechanism of immune privilege","volume":"270","author":"Griffith","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80225-2_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/377630a0","article-title":"A role for CD95 ligand in preventing graft rejection","volume":"377","author":"Bellgrau","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(98)80225-2_bib6","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.4049\/jimmunol.158.9.4122","article-title":"Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus","volume":"158","author":"Hunt","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib7_1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI119273","article-title":"Fas Ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?","volume":"99","author":"Saas","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S0952-7915(98)80225-2_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","article-title":"Melanoma cell expression of Fas(Apo-1\/CD95) ligand: implications for tumor immune escape","volume":"274","author":"Hahne","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80225-2_bib9_1","doi-asserted-by":"crossref","first-page":"13862","DOI":"10.1073\/pnas.94.25.13862","article-title":"Gene transfer of Fas ligand induces tumor regression in vivo","volume":"94","author":"Arai","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80225-2_bib10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.184.3.1075","article-title":"The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand","volume":"184","author":"O'Connell","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib11_1","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1073\/pnas.94.12.6420","article-title":"Expression of Fas ligand in liver metastases of human colonic adenocarcinomas","volume":"94","author":"Shiraki","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80225-2_bib12_1","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.4049\/jimmunol.158.10.4521","article-title":"Role of Fas ligand (CD95L) in immune escape : the tumor cell strikes back","volume":"158","author":"Walker","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib13","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.4049\/jimmunol.159.8.4006","article-title":"Fas (CD95, Apo-1) antigen expression and function in murine mast cells","volume":"159","author":"Hartmann","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib14","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4049\/jimmunol.156.7.2357","article-title":"Different susceptibility of cytotoxic T cells to CD95 (Fas\/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo","volume":"156","author":"Ehl","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib15_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nm0297-165","article-title":"Antitumor effect of locally produced CD95 ligand","volume":"3","author":"Seino","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib16_1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-199710150-00018","article-title":"Transplantation of CD95 ligand-expressing grafts. Influence of transplantation site and difficulty in protecting allo- and xenografts","volume":"64","author":"Seino","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/S0952-7915(98)80225-2_bib17_1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm0897-843","article-title":"Inhibition of the alloantibody response by CD95 ligand","volume":"3","author":"Arai","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib18_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(00)80178-6","article-title":"The role of Fas in autoimmune diabetes","volume":"89","author":"Chervonsky","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(98)80225-2_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.187.1.123","article-title":"Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand","volume":"187","author":"Suzuki","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib20","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.4049\/jimmunol.155.9.4147","article-title":"Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen","volume":"155","author":"Abreu-Martin","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib21","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V90.5.1952","article-title":"Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street","volume":"90","author":"Zeytun","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(98)80225-2_bib22","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.4049\/jimmunol.159.9.4261","article-title":"Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle","volume":"159","author":"Dao","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib23","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.4049\/jimmunol.159.8.3816","article-title":"Maintenance of clonotype specificity in CD95\/Apo-1\/Fas-mediated apoptosis of mature T lymphocytes","volume":"159","author":"Hornung","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib24","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1084\/jem.186.11.1939","article-title":"T cell receptor signals enhance susceptibility to Fas-mediated apoptosis","volume":"186","author":"Wong","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib25","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.4049\/jimmunol.159.8.3808","article-title":"Costimulatory signals through B7.1\/CD28 prevent T cell apoptosis during target cell lysis","volume":"159","author":"Daniel","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.187.5.711","article-title":"CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis","volume":"187","author":"Algeciras","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib27","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.185.10.1837","article-title":"Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas\/FasL-mediated apoptosis","volume":"185","author":"Zhang","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib28","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1126\/science.279.5359.2015a","article-title":"Constitutive expression of FasL and thyrocytes (technical comment)","volume":"279","author":"Stokes","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80225-2_bib29","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1126\/science.279.5359.2015a","article-title":"Constitutive expression of FasL and thyrocytes (technical comment)","volume":"279","author":"Fiedler","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80225-2_bib30","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1126\/science.279.5359.2015a","article-title":"Constitutive expression of FasL and thyrocytes (technical comment)","volume":"279","author":"Papoff","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80225-2_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1006\/bbrc.1997.7357","article-title":"Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells","volume":"238","author":"Oyaizu","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0952-7915(98)80225-2_bib32_1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1084\/jem.186.12.2045","article-title":"Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing","volume":"186","author":"Suda","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib33_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib34_1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity","volume":"187","author":"Schneider","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib35","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.94.8.3914","article-title":"Polymorphism of murine Fas ligand that affects the biological activity","volume":"94","author":"Kayagaki","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80225-2_bib36","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.157.9.3918","article-title":"Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand","volume":"157","author":"Suda","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.160.1.134","article-title":"The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression","volume":"160","author":"Faris","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/intimm\/6.10.1567","article-title":"Human Fas ligand: gene structure, chromosomal location and species specificity","volume":"6","author":"Takahashi","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib39_1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.159.4.1594","article-title":"Human monocytic cells contain high levels of intracellular Fas ligand. Rapid release following cellular activation","volume":"159","author":"Kiener","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib40","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.182.6.1777","article-title":"Metalloproteinase-mediated release of human Fas ligand","volume":"182","author":"Kayagaki","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib41","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/eji.1830250828","article-title":"Regulation of cell surface Apo-1\/Fas (CD95) ligand expression by metalloproteases","volume":"25","author":"Mariani","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib43","doi-asserted-by":"crossref","first-page":"28191","DOI":"10.1074\/jbc.272.45.28191","article-title":"Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells","volume":"272","author":"Hug","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80225-2_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0167-5699(95)80079-4","article-title":"Fas and FasL in the homeostatic regulation of immune responses","volume":"16","author":"Lynch","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/S0952-7915(98)80225-2_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/1523-1747.ep12334273","article-title":"Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts","volume":"108","author":"Freiberg","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib46","first-page":"3253","article-title":"Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells","volume":"17","author":"Ohtsuki","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/S0952-7915(98)80225-2_bib47","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T","article-title":"Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage","volume":"28","author":"Mariani","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/cimm.1997.1211","article-title":"Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells","volume":"181","author":"An","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib49","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/eji.1830270433","article-title":"Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas\/Apo-1) ligand expression and function","volume":"27","author":"Daniel","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib50","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/sj.leu.2400815","article-title":"Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis","volume":"11","author":"Xerri","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/S0952-7915(98)80225-2_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V90.1.12.12_12_20","article-title":"Constitutive expression of Fas (Apo-1\/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance","volume":"90","author":"Villunger","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(98)80225-2_bib52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","article-title":"Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage","volume":"31","author":"Ohshima","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/S0952-7915(98)80225-2_bib53","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nm0596-574","article-title":"Involvement of the CD95 (Apo-1\/Fas) receptor\/ligand system in drug-induced apoptosis in leukemia cells","volume":"2","author":"Friesen","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1997.d01-2113.x","article-title":"Constitutive expression of Fas ligand in large granular lymphocyte leukaemia","volume":"97","author":"Perzova","year":"1997","journal-title":"Brit J Haematol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1750-3639.1997.tb00889.x","article-title":"Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors","volume":"7","author":"Gratas","year":"1997","journal-title":"Brain Pathol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib56_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI1165","article-title":"Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L)","volume":"101","author":"Gutierrez-Steil","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S0952-7915(98)80225-2_bib57_1","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1172\/JCI119814","article-title":"Regression of basal cell carcinoma by intralesional interferon- alpha treatment is mediated by CD95 (Apo-1\/Fas)-CD95 ligand-induced suicide","volume":"100","author":"Buechner","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S0952-7915(98)80225-2_bib58","first-page":"881","article-title":"Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells","volume":"57","author":"Turley","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80225-2_bib59","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1210\/jcem.82.9.4360","article-title":"Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells","volume":"82","author":"Bamberger","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0952-7915(98)80225-2_bib60","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nm1296-1361","article-title":"Lymphocyte apoptosis induced by CD95 (Apo-1\/Fas) ligand-expressing tumor cells- A mechanism of immune evasion?","volume":"2","author":"Strand","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib61_1","first-page":"1007","article-title":"Human lung carcinomas express Fas ligand","volume":"57","author":"Niehans","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80225-2_bib62","first-page":"3823","article-title":"The CD95 (Apo-1\/Fas) system mediates drug-induced apoptosis in neuroblastoma cells","volume":"57","author":"Fulda","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80225-2_bib63","first-page":"427","article-title":"Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death","volume":"83","author":"Imai","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0952-7915(98)80225-2_bib64_1","first-page":"1741","article-title":"Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis","volume":"58","author":"Ungefroren","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80225-2_bib65","first-page":"3861","article-title":"Expression of Fas and Fas ligand in the testes and testicular germ cell tumors: an immunohistochemical study","volume":"17","author":"Sugihara","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/S0952-7915(98)80225-2_bib66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1172\/JCI119174","article-title":"Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (Apo-1\/Fas) receptor\/ligand system and involves activation of wild-type p53","volume":"99","author":"M\u00fcller","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S0952-7915(98)80225-2_bib67","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.leu.2400827","article-title":"Deficient activation of the CD95 (Apo-1\/Fas) system in drug- resistant cells","volume":"11","author":"Friesen","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/S0952-7915(98)80225-2_bib68","first-page":"3331","article-title":"Drug-induced apoptosis is associated with enhanced Fas (Apo-1\/CD95) ligand expression but occurs independently of Fas (Apo-1\/CD95) signaling in human T-acute lymphatic leukemia cells","volume":"57","author":"Villunger","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80225-2_bib69","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1074\/jbc.273.14.8048","article-title":"Role of reactive oxygen intermediates in activation-induced CD95 (apo-1\/Fas) ligand expression","volume":"273","author":"Bauer","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80225-2_bib70","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/375497a0","article-title":"Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120","volume":"375","author":"Westendorp","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(98)80225-2_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.186.1.7","article-title":"Evasion of cytotoxic T lymphocyte (CTL) responses by nef- dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells","volume":"186","author":"Xu","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(98)80225-2_bib72","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1099\/0022-1317-78-12-3277","article-title":"Role of the Fas\/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator","volume":"78","author":"Chen","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/S0952-7915(98)80225-2_bib73","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/sj.onc.1201070","article-title":"ICE-proteases mediate HTLV-I Tax-induced apoptotic T-cell death","volume":"14","author":"Chlichlia","year":"1997","journal-title":"Oncogene"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791598802252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791598802252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:14:02Z","timestamp":1760602442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791598802252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["S0952791598802252"],"URL":"https:\/\/doi.org\/10.1016\/s0952-7915(98)80225-2","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[1998,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor expression of Fas ligand (CD95L) and the consequences","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0952-7915(98)80225-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}